Thursday, February 24, 2022

INDIGO

INDIGO(InterGlobe Aviation Limited)

05.01.2023 - GS on INDIGO Maintain Buy CMP 2100 Target 2180
28.12.2022 - Motilal Oswal on Indigo Maintain Buy CMP 2100 Target 2400
14.12.2022 - CS on INDIGO Maintain Outperform CMP 2020 Target 2350
24.11.2022 - CS on INDIGO Maintain Outperform CMP 1894 Target 2350
18.11.2022 - MS on INDIGO Maintain Overweight CMP 1758 Target 2749
06.10.2022 - CS on INDIGO Maintain Outperform CMP 1817 Target 2350
04.10.2022 - GS on INDIGO Maintain Buy CMP 1849 Target 2219
04.08.2022 - JpMorgan on INDIGO Maintain Overweight CMP 2080.55 Target 2200
11.07.2022 - CS on INDIGO Maintain Outperform CMP 1686 Target 2200
10.06.2022 - CS on INDIGO Maintain Outperform CMP 1753.8 Target 2200
26.05.2022 - CS on INDIGO Maintian Outperform CMP 1813.75 Target 2200
26.05.2022 - JpMorgan on INDIGO Maintain Overweight CMP 1813.75 Target 2000
25.03.2022 - JpMorgan on INDIGO Upgrade Neutral CMP 1934 Target 1825
11.03.2022 - CS on INDIGO Maintan Outperform CMP 1837.2 Target 2500
04.03.2022 - MS on INDIGO Maintain Overweight CMP 1730 Target 2795
25.02.2022 - MS on INDIGO Maintain Overweight CMP 1831 Target 2759
07.02.2022 - GS on INDIGO Maintain Neutral CMP 2161 Target 2150
07.02.2022 - Kotak Inst Eqt on INDIGO Maintain Buy CMP 2161 Target 3000

HSBC ON INTERGLOBE AVIATION : 17.06.2021

• Maintain Reduce, Target at Rs 1,315/share
• Aggressive growth without support
* Q4FY21 loss more than double consensus expectation
* Liquidity and working capital worsen
• Weak demand, rising fuel price, unfavourable forex

GS ON INDIGO : 08.06.2021

* MAINTAIN BUY TARGET: 1,960
* IndiGo remains Goldman Sachs's preferred aviation pick
* Continue To Recommend It As Our Preferred Aviation Stock
* Like Due To Its Balancesheet Strength Vs Peers
* Lower Estimates For FY22
* Near-term Focus Of Market Will Remain On Rate Of Infection

CREDIT SUISSE ON INDIGO : 08.06.2021

* MAINTAIN OUTPERFORM TARGET: 2,100
* CS maintains Outperform call on IndiGo on its positioning, structural cash flows & opportunity
* Consolidation Is Playing Out
* Competitors Pulling Back Passenger Capacity Driven By Losses/Lessors Disputes
* Stay OP On Positioning, Structural Cash Flows & Opportunity
* See 15% CAGR For FY21-30 Taking Co To 450/870 Planes By FY25/30

CITI ON INDIGO : 08.06.2021

* Maintain Sell, Target at Rs 1,330/share
* IndiGo reported a weak Q4'FY21 as better yield was offset by high fuel costs and forex losses
* Cash burn has increased QoQ
* Demand headwinds continue and competitors are ramping up capacities
* Maintain Sell, Target Price cut to Rs 1,330 from Rs 1,550/share

CITI ON INDIGO : 08.06.2021

* MAINTAIN SELL TARGET: 1,330 (PREV TGT: 1,550)
* Citi maintains SELL call on IndiGO, target cut to Rs.1,330/sh
* Market Share Could Be Peaking
* Target Price Cut Primarily Due To Cuts In FY22 Estimates

ERIS

ERIS(Eris Lifesciences Ltd) 18.01.2023 -  Macquarie  on  ERIS Maintain Outperform CMP 625.75 Target 830